Literature DB >> 26030936

Medical devices; immunology and microbiology devices; classification of multiplex nucleic acid assay for identification of microorganisms and resistance markers from positive blood cultures. Final order.

.   

Abstract

The Food and Drug Administration (FDA) is classifying multiplex nucleic acid assay for identification of microorganisms and resistance markers from positive blood cultures into class II (special controls). The special controls that will apply to this device are identified in this order and will be part of the codified language for the multiplex nucleic acid assay for identification of microorganisms and resistance markers from positive blood cultures. The Agency is classifying the device into class II (special controls) in order to provide a reasonable assurance of safety and effectiveness of the device.

Mesh:

Year:  2015        PMID: 26030936

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  2 in total

1.  Cost-Effectiveness Of Culture-Based Versus Empirical Antibiotic Treatment For Hospitalized Adults With Community-Acquired Pneumonia In Indonesia: A Real-World Patient-Database Study.

Authors:  Abdul Khairul Rizki Purba; Purwantyastuti Ascobat; Armen Muchtar; Laksmi Wulandari; Jan-Willem Dik; Annette d'Arqom; Maarten J Postma
Journal:  Clinicoecon Outcomes Res       Date:  2019-11-29

2.  A highly multiplexed broad pathogen detection assay for infectious disease diagnostics.

Authors:  Jeffrey W Koehler; Christina E Douglas; Timothy D Minogue
Journal:  PLoS Negl Trop Dis       Date:  2018-11-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.